Switzerland
Swiss stock market sets another record high
Switzerland’s SMI share index reached a new all-time high on Monday, closing up 0.6% at 15,192 points after touching 15,272 during the session. Traders said defensive blue-chip stocks helped the market outperform major European indices amid uncertainty in the technology sector.

The SMI closed at 15,192 points, a fresh record, after climbing as high as 15,272 during Monday’s session. The index gained 0.6% by the close, extending the Swiss market’s strong start to the week. It briefly gave back ground after Wall Street opened weakly, but still finished higher.
Switzerland’s defensive blue-chip companies helped the market hold up while uncertainty weighed on technology shares. The contrast showed in the closing numbers: the German DAX and French CAC 40 both ended lower, while the SMI advanced. Traders pointed to the market’s defensive character as a reason it was less exposed to jitters around AI and semiconductors.
That resilience did not mean every Swiss share rose. Healthcare names led much of the advance, while several chip-linked stocks slipped. The record close reflected strength in the index’s more defensive heavyweights, even as investors remained cautious about the technology sector.
Track the Tech-Sector Nerves
Technology-sector uncertainty was the main source of caution on the trading floor. Traders cited questions over the planned initial public offering of AI platform operator Anthropic and the future performance of semiconductor maker Nvidia. Nvidia’s results were due the following day, and traders said nervousness was already palpable ahead of the announcement.
The unease was visible across shares linked to chips and artificial intelligence. Experts described the mood as a “tech hangover”, but said its effect on Switzerland was limited. The SMI’s defensive blue chips helped shield the broader market from some of the pressure affecting other exchanges.
Swiss companies with technology exposure still felt the pullback. ABB fell 1.1% and VAT lost 0.6%. In the broader market, Comet and Huber+Suhner each declined 1.6%, while Inficon shed 1.5%. Those losses remained relatively moderate as healthcare and other blue-chip shares supported the index. The market’s next test was Nvidia’s results, with traders watching for their effect on sentiment toward the wider chip and AI sectors.
Follow the Healthcare Leaders
Healthcare shares helped set the tone, with Alcon and Novartis each rising 1.3% and Roche gaining 1.1%. Lonza added 0.6%. The gains helped offset weakness among technology-linked names and underscored the support that defensive companies provided to the SMI.
Richemont led the index, rising 2.7% as the luxury group’s shares began to recover. The move followed a 3.8% fall on Friday, when investors reacted poorly to the company’s annual results. Its rebound was the day’s strongest SMI performance, but healthcare shares also featured prominently among the market’s gainers.
The session’s advance was therefore uneven. While the index reached new highs, ABB, VAT and several broader-market chip and technology companies fell. The mix of gains and losses helps explain how the SMI could outperform weaker European markets without a broad-based rise across Swiss shares. Investors seeking the day’s clearest positive signals found them in healthcare and in Richemont’s recovery.
Watch Nvidia and the Next Session
The SMI’s record came as major European indices moved in the opposite direction. The German DAX and French CAC 40 both closed lower, while Switzerland’s benchmark finished up 0.6%. Traders attributed the difference in part to the SMI’s defensive blue chips, which were less affected by the uncertainty surrounding technology stocks.
The record was not a straight-line climb. The index reached 15,272 during the afternoon, then slipped back slightly after Wall Street started weakly. It nevertheless ended at 15,192, setting a new closing high. The session put the role of Switzerland’s large defensive companies in focus as investors weighed pressure on AI and semiconductor shares against strength in healthcare.
Attention now turns to Nvidia’s results, which traders were already watching closely. The company’s performance was a key source of uncertainty for the chip sector, alongside the planned Anthropic IPO. For Swiss investors, Monday’s trading showed how the SMI’s composition can help it weather technology-market jitters, while leaving individual technology-linked shares exposed to shifts in sentiment.